公司资料
Teleflex 股价、新闻与催化剂
- 股票代码:
- TFX
- 交易所:
- NYSE
- 行业:
- MedTech
- 所在地:
- United States
股票表现
126.11 USD (+0.86%)
收盘价
最后更新: 2026年10月1日
5.54B USD
市值
股价为何变动
截至 2026年10月1日，TFX 上涨 0.86%，收于 $126.11。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Diversified Medical Technology Company
Teleflex develops medical devices used in vascular access, interventional cardiology and radiology, surgery, anesthesia, emergency medicine, and urology. Its portfolio includes established brands such as Arrow, QuikClot, LMA, Weck, Barrigel, and Rüsch.
Vascular and Emergency Medicine
The vascular business includes central venous access, arterial access, intraosseous access, hemostatic products, and emergency-care technologies. EZPLAZ freeze-dried plasma extends the portfolio into a biologic product intended for settings where conventional plasma may be unavailable.
Interventional Portfolio
Teleflex's interventional business includes coronary and peripheral devices, catheter-based technologies, and the acquired BIOTRONIK vascular intervention portfolio. These products are used by interventional cardiologists and radiologists in minimally invasive procedures.
Surgical Products
The surgical portfolio includes ligation, closure, specialty instruments, and other products used in operating rooms. Brands such as Weck and Deknatel provide recurring demand across a broad range of procedures.
Freesolve Resorbable Scaffold
Freesolve is a drug-eluting resorbable magnesium scaffold designed to provide temporary vessel support and then dissolve. The program includes completed long-term follow-up, an ex-U.S. randomized study, and a U.S. pivotal trial.
未来催化剂
- Late-2027 data readout from the randomized BIOMAG-II study of the Freesolve resorbable magnesium scaffold.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。